Judit Diaz
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tetrahydrocannabinol/cannabidiol in the treatment of restless legs syndrome.
Journal: Journal of neurology
Published: April 12, 2026
Clinical characteristics and impact on patient-reported outcomes and quality of life of people with ambulatory secondary progressive multiple sclerosis: DISCOVER study.
Journal: Multiple sclerosis and related disorders
Published: September 19, 2023
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology.
Journal: Frontiers in immunology
Published: December 23, 2021
Early predictive risk factors for dimethyl fumarate-associated lymphopenia in patients with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: December 03, 2021
Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: February 22, 2021
Cancer diagnosis in a Spanish cohort of multiple sclerosis patients under dimethylfumarate treatment.
Journal: Multiple sclerosis and related disorders
Published: December 30, 2020
Highlights from the 2019 European Congress on Treatment and Research in Multiple Sclerosis (ECTRIMS 2019).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 05, 2020
Tolerability and safety of dimethyl fumarate in relapsing multiple sclerosis: a prospective observational multicenter study in a real-life Spanish population.
Journal: Journal of neurology
Published: February 11, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026